INHIBITION OF HCV REPLICATION BY CCR5 BLOCKADE WITH CENICRIVIROC AND MARAVIROC

被引：1
|
作者：
Sherman, K. E. [1 ]
Kong, L. [1 ]
Blackard, J. T. [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Digest Dis, Cincinnati, OH USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31109-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0906
引用
收藏
页码：S684 / S684
页数：1
相关论文
共 50 条
  • [31] CENICRIVIROC MESILATE Chemokine CCR2/CCR5 Receptor Antagonist Anti-HIV Agent
    Reviriego, C.
    DRUGS OF THE FUTURE, 2011, 36 (07) : 511 - 517
  • [32] CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
    Asim Pervaiz
    Michael Zepp
    Saqib Mahmood
    Doaa Mohamed Ali
    Martin R. Berger
    Hassan Adwan
    Cellular Oncology, 2019, 42 : 93 - 106
  • [33] MARAVIROC, A CCR5 ANTAGONIST, PREVENTS DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN A MOUSE MODEL
    Ochoa-Callejero, L.
    Perez, L.
    Rubio, S.
    Oteo, J. A.
    Martinez, A.
    Blanco, J. R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S437 - S437
  • [34] Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
    Ochoa-Callejero, Laura
    Perez-Martinez, Laura
    Rubio-Mediavilla, Susana
    Oteo, Jose A.
    Martinez, Alfredo
    Blanco, Jose R.
    PLOS ONE, 2013, 8 (01):
  • [35] Therapeutic potential of blocking CCR5 by maraviroc in breast cancer bone metastasis
    Pervaiz, Asim
    Zepp, Michael
    Ali, Doaa M.
    Berger, Martin R.
    Adwan, Hassan
    CANCER RESEARCH, 2016, 76
  • [36] CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination
    Mencarelli, Andrea
    Graziosi, Luigina
    Renga, Barbara
    Cipriani, Sabrina
    D'Amore, Claudio
    Francisci, Daniela
    Bruno, Angela
    Baldelli, Franco
    Donini, Annibale
    Fiorucci, Stefano
    TRANSLATIONAL ONCOLOGY, 2013, 6 (06) : 784 - 793
  • [37] Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
    Latinovic, Olga
    Kuruppu, Janaki
    Davis, Charles
    Le, Nhut
    Heredia, Alonso
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1497 - 1510
  • [38] CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
    Pervaiz, Asim
    Zepp, Michael
    Mahmood, Saqib
    Ali, Doaa Mohamed
    Berger, Martin R.
    Adwan, Hassan
    CELLULAR ONCOLOGY, 2019, 42 (01) : 93 - 106
  • [39] Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications
    Xu, Guoyan G.
    Guo, Jia
    Wu, Yuntao
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (13) : 1504 - 1514
  • [40] Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens
    Kravchenko, A. V.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (11) : 125 - +
12345